Irrespective of the causes, the results show that over the last twenty years, type 2 diabetes can now be considered common among relatively young people in the UK, which could have major implications for greater health ...
Metabolic Solutions Development Co. LLC announced Wednesday the publication of data in the latest issue of the scientific journal PLOS ONE on a new drug target for treating type 2 diabetes by boosting the body's sensitivity ...
* Must be complete